There was a statistically significant difference for PRKRA/CHROMR ratio when comparing pathological (both LGG and GBM) and healthy (brain cortex) brain tissue expression, confirming our previous observation from our in-house RNA-seq data. The gene discussed is PRKRA; the disease is glioblastoma.